Zhejiang Jolly Pharmaceutical Co Ltd

SHE:300181 China Drug Manufacturers - General
Market Cap
$1.58 Billion
CN¥11.59 Billion CNY
Market Cap Rank
#6600 Global
#1020 in China
Share Price
CN¥16.52
Change (1 day)
+0.67%
52-Week Range
CN¥15.59 - CN¥20.53
All Time High
CN¥20.53
About

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kid… Read more

Zhejiang Jolly Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2024: 0.03%

Zhejiang Jolly Pharmaceutical Co Ltd (300181) has an Asset Resilience Ratio of 0.03% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥1.00 Million
Cash + Short-term Investments
Total Assets
CN¥3.86 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Zhejiang Jolly Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jolly Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.00 Million 0.03%
Total Liquid Assets CN¥1.00 Million 0.03%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Jolly Pharmaceutical Co Ltd maintains only 0.03% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Jolly Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jolly Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
Drug Manufacturers - General 5.75%
Hunan Jingfeng Pharmaceutical
SHE:000908
Drug Manufacturers - General 0.38%
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
Drug Manufacturers - General 5.37%
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367
Drug Manufacturers - General 32.14%
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
Drug Manufacturers - General 0.53%
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
Drug Manufacturers - General 0.00%
PharmGen Science Inc
KO:004720
Drug Manufacturers - General 0.16%

Annual Asset Resilience Ratio for Zhejiang Jolly Pharmaceutical Co Ltd (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Jolly Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 4.16% CN¥151.00 Million CN¥3.63 Billion +3.87pp
2022-12-31 0.30% CN¥10.83 Million CN¥3.64 Billion -2.09pp
2021-12-31 2.38% CN¥65.52 Million CN¥2.75 Billion -0.09pp
2020-12-31 2.47% CN¥61.04 Million CN¥2.47 Billion +2.46pp
2019-12-31 0.01% CN¥300.00K CN¥2.05 Billion -0.14pp
2018-12-31 0.15% CN¥3.19 Million CN¥2.11 Billion -4.77pp
2017-12-31 4.92% CN¥106.00 Million CN¥2.15 Billion -2.51pp
2016-12-31 7.43% CN¥151.50 Million CN¥2.04 Billion -4.41pp
2015-12-31 11.84% CN¥219.13 Million CN¥1.85 Billion --
pp = percentage points